How effective is Prolensa for glaucoma according to recent clinical studies or reviews?
Prolensa is not indicated for the treatment of glaucoma and is not supported by current clinical guidelines or approvals for that use.
Overview
Some individuals exploring treatment options for glaucoma may wonder if anti-inflammatory eye drops like Prolensa have a role in managing intraocular pressure or disease progression. However, Prolensa’s intended use differs significantly from glaucoma treatments.
- Prolensa is a topical nonsteroidal anti-inflammatory drug (NSAID) used after cataract surgery.
- It is not designed to reduce intraocular pressure, which is the primary concern in glaucoma care.
- Approved glaucoma treatments typically include beta blockers, prostaglandin analogs, or carbonic anhydrase inhibitors.
This helps explain why Prolensa is not recommended for glaucoma therapy.
Detailed Information
How it works
Prolensa may work by inhibiting prostaglandin synthesis, which reduces ocular inflammation and pain after surgery. This anti-inflammatory effect helps prevent complications like cystoid macular edema, but it does not target the mechanisms behind glaucoma.
Clinical applications
According to the published overview of Prolensa, this medication is approved for treating inflammation and reducing eye pain in patients who have undergone cataract surgery. There is no mention of efficacy in treating or managing glaucoma.
Safety and Effectiveness
Safety profile
Per the documentation provided by the Ministry of Health (MOH Prolensa document), common side effects include eye irritation, impaired healing, and increased eye pressure in rare cases. These risks further indicate that Prolensa is not ideal for glaucoma patients unless specifically prescribed post-surgery.
FDA approval and indications
Prolensa is FDA-approved specifically for use after cataract extraction, not for the treatment of glaucoma. No clinical reviews from official labeling suggest it prevents optic nerve damage or controls intraocular pressure.
Access and Availability
How to obtain safely
Prolensa is available by prescription through licensed pharmacies. IsraelPharm offers access to Prolensa for those who need anti-inflammatory support following eye procedures. Always consult with your eye doctor before use—especially if you have a history of glaucoma or elevated eye pressure.
Key Takeaways
- Prolensa is not indicated or approved for glaucoma treatment.
- It may help reduce inflammation and pain after cataract surgery.
- No clinical studies support Prolensa’s use for intraocular pressure control.
- Patients with glaucoma should rely on medications specifically approved for eye pressure management.
FAQ
Is Prolensa used to treat glaucoma?
No, Prolensa is not approved for treating glaucoma. It is used to reduce inflammation and pain after eye surgery, not to lower intraocular pressure.
Can Prolensa raise eye pressure?
According to the documentation, a small number of patients may experience increased intraocular pressure with use. Always monitor with your doctor if you have glaucoma.
What’s the difference between Prolensa and glaucoma eye drops?
Prolensa is an NSAID to control inflammation, while glaucoma medications focus on reducing eye pressure through different mechanisms like improving fluid drainage or reducing fluid production.
Is Prolensa safe for glaucoma patients post-surgery?
It may be prescribed after cataract surgery even in patients with glaucoma, but only under close monitoring by an eye specialist due to the rare risk of pressure changes.
Where can I buy Prolensa online?
IsraelPharm provides Prolensa for eligible patients with prescriptions. Speak with your provider to ensure it’s appropriate for your condition.


